Literature DB >> 17416486

Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet.

Kristopher J Bough1, Maryse Paquet, Jean-François Paré, Bjørnar Hassel, Yoland Smith, Randy A Hall, Raymond Dingledine.   

Abstract

Excessive glutamatergic neurotransmission is considered an underlying factor of epilepsy. Energy-dependent glutamate transporters clear extracellular glutamate to limit neuronal excitability. Evidence suggests that reduced expression and/or activity of glutamate transporters contribute to hyperexcitability and progressive seizure activity in rats. By comparison, treatment with the anticonvulsant ketogenic diet (KD) results in increased mRNA expression of the neuronal glutamate transporter EAAC1, elevated energy reserves, and an increased resistance to seizures in rats. The goal of the current study was to determine whether the expression and/or re-uptake activity of glutamate transporters were elevated in hippocampal tissue of rats after KD treatment. Rats were fed either a ketogenic- or control diet for 4-5 weeks. Western blot analysis showed that protein levels of EAAC1, GLT-1 and GLAST glutamate transporters were not changed in hippocampus, cerebral cortex, or cerebellum after KD. Electron microscopic evidence indicated that the KD did not affect hippocampal EAAC1 distribution. In addition, the re-uptake activity of (3)H-glutamate into hippocampal proteoliposomes was similar in both KD and control tissue extracts. These multiple studies suggest that the anticonvulsant nature of the KD does not stem from enhanced glutamate re-uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416486     DOI: 10.1016/j.eplepsyres.2007.03.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

2.  Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminones.

Authors:  Patrice L Jackson; K R Scott; William M Southerland; Ya-Yin Fang
Journal:  Bioorg Med Chem       Date:  2008-11-13       Impact factor: 3.641

Review 3.  Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Authors:  Susan A Masino; Jonathan D Geiger
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

Review 4.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

5.  The ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from Strasbourg.

Authors:  Astrid Nehlig; Franck Dufour; Marianne Klinger; Lisa B Willing; Ian A Simpson; Susan J Vannucci
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

Review 6.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

Review 7.  Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Authors:  Joeri Van Liefferinge; Ann Massie; Jeanelle Portelli; Giuseppe Di Giovanni; Ilse Smolders
Journal:  Front Cell Neurosci       Date:  2013-08-30       Impact factor: 5.505

8.  Metabolic control of vesicular glutamate transport and release.

Authors:  Narinobu Juge; John A Gray; Hiroshi Omote; Takaaki Miyaji; Tsuyoshi Inoue; Chiaki Hara; Hisayuki Uneyama; Robert H Edwards; Roger A Nicoll; Yoshinori Moriyama
Journal:  Neuron       Date:  2010-10-06       Impact factor: 18.688

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.